
Philip Morris (PM) Stock Forecast & Price Target
Philip Morris (PM) Analyst Ratings
Bulls say
Philip Morris Intl is supported by a resilient core cigarette franchise that continues to deliver strong pricing and volume stability while funding a faster mix shift toward smoke-free products. Its long-term upside is anchored by IQOS, the leading heated-tobacco brand in most markets, and ZYN, whose U.S. share gains and expanding portfolio suggest durable growth despite heavier near-term investment that can pressure margins. With about 41.5% of revenue from reduced-risk products and management still targeting 6%-8% organic sales growth, 8%-10% organic operating profit growth, and 9%-11% EPS growth on a constant-currency basis, the business appears well positioned for both earnings expansion and de-risking over time.
Bears say
Philip Morris Intl is exposed to slowing growth if IQOS loses share and U.S. nicotine pouch competition intensifies, which could sharply reduce reduced-risk momentum despite 41.5% of revenue coming from that segment as of 2025. At the same time, higher-than-expected declines in combustible volumes would be difficult to offset with pricing, pointing to revenue pressure, gross margin compression, and weaker earnings. Delays in the IQOS PMTA process in the U.S. and unforeseen FDA compliance hurdles add regulatory overhang, increasing the risk of further market share erosion and a lower trading multiple.
This aggregate rating is based on analysts' research of Philip Morris and is not a guaranteed prediction by Public.com or investment advice.
Philip Morris (PM) Analyst Forecast & Price Prediction
Start investing in Philip Morris (PM)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Philip Morris (PM) Forecast
Philip Morris (PM) Analyst Forecast & Price Prediction
Start investing in Philip Morris (PM)
Order type
Buy in
Order amount
Est. shares
0 shares